Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	REN ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-25 ERVK-24	6.46e-13	37	117	9	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	REN ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-25 ERVK-24	8.42e-13	38	117	9	GO:0070001
GeneOntologyMolecularFunction	RNA stem-loop binding	FMR1 ERVK-7 ERVK-10 ERVK-8	6.20e-06	21	117	4	GO:0035613
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-7 ERVK-10 ERVK-8	3.13e-05	11	117	3	GO:0004523
GeneOntologyMolecularFunction	P-type manganese transporter activity	ATP2C1 ATP2C2	3.40e-05	2	117	2	GO:0140613
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-7 ERVK-10 ERVK-8	6.81e-05	14	117	3	GO:0003964
GeneOntologyMolecularFunction	arylamine N-acetyltransferase activity	NAT1 NAT2	1.02e-04	3	117	2	GO:0004060
GeneOntologyMolecularFunction	endopeptidase activity	USP34 REN ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-25 ERVK-24	2.22e-04	430	117	10	GO:0004175
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1D MYO9B DNAH1 MYO3A DNAH17	6.55e-04	118	117	5	GO:0003774
Domain	Arylamine_N-AcTrfase	NAT1 NAT2	3.31e-05	2	108	2	IPR001447
Domain	Acetyltransf_2	NAT1 NAT2	3.31e-05	2	108	2	PF00797
Domain	P-type_ATPase_IIA_PMR1	ATP2C1 ATP2C2	3.31e-05	2	108	2	IPR006413
Domain	Rab_bind	RGPD4 RGPD3	6.83e-04	7	108	2	PF16704
Domain	GCC2_Rab_bind	RGPD4 RGPD3	6.83e-04	7	108	2	IPR032023
Domain	PTEN_C2	GAK TNS3	9.07e-04	8	108	2	PF10409
Domain	PTEN_C2	GAK TNS3	9.07e-04	8	108	2	SM01326
Domain	C2_TENSIN	GAK TNS3	9.07e-04	8	108	2	PS51182
Domain	Tensin_lipid_phosphatase_dom	GAK TNS3	9.07e-04	8	108	2	IPR029023
Domain	Tensin_C2-dom	GAK TNS3	9.07e-04	8	108	2	IPR014020
Domain	PPASE_TENSIN	GAK TNS3	1.16e-03	9	108	2	PS51181
Domain	Myosin_head_motor_dom	MYO1D MYO9B MYO3A	1.37e-03	38	108	3	IPR001609
Domain	MYOSIN_MOTOR	MYO1D MYO9B MYO3A	1.37e-03	38	108	3	PS51456
Domain	Myosin_head	MYO1D MYO9B MYO3A	1.37e-03	38	108	3	PF00063
Domain	MYSc	MYO1D MYO9B MYO3A	1.37e-03	38	108	3	SM00242
Domain	-	RGPD4 RGPD3	1.45e-03	10	108	2	1.10.220.60
Domain	Grip	RGPD4 RGPD3	1.76e-03	11	108	2	SM00755
Domain	GRIP	RGPD4 RGPD3	1.76e-03	11	108	2	PF01465
Domain	Tyr_kinase_rcpt_2_CS	INSR LTK	1.76e-03	11	108	2	IPR002011
Domain	Ran_BP1	RGPD4 RGPD3	2.11e-03	12	108	2	PF00638
Domain	RANBD1	RGPD4 RGPD3	2.11e-03	12	108	2	PS50196
Domain	GRIP_dom	RGPD4 RGPD3	2.11e-03	12	108	2	IPR000237
Domain	RECEPTOR_TYR_KIN_II	INSR LTK	2.11e-03	12	108	2	PS00239
Domain	GRIP	RGPD4 RGPD3	2.11e-03	12	108	2	PS50913
Domain	RanBD	RGPD4 RGPD3	2.48e-03	13	108	2	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD3	2.48e-03	13	108	2	IPR000156
Domain	IMPORTIN_B_NT	TNPO2 IPO9	2.88e-03	14	108	2	PS50166
Domain	Neurexin-like	CADM3 CNTNAP1	2.88e-03	14	108	2	IPR003585
Domain	4.1m	CADM3 CNTNAP1	2.88e-03	14	108	2	SM00294
Domain	IBN_N	TNPO2 IPO9	3.31e-03	15	108	2	PF03810
Domain	ARM-type_fold	USP34 TNPO2 INTS1 TOGARAM1 FRYL WDFY4 IPO9	3.56e-03	339	108	7	IPR016024
Domain	IBN_N	TNPO2 IPO9	3.77e-03	16	108	2	SM00913
Domain	ATPase_P-typ_TM_dom	ATP2C1 ATP2C2	3.77e-03	16	108	2	IPR023298
Domain	-	ATP2C1 ATP2C2	3.77e-03	16	108	2	1.20.1110.10
Domain	ATPase_P-typ_cation-transptr_C	ATP2C1 ATP2C2	4.26e-03	17	108	2	IPR006068
Domain	Cation_ATPase_C	ATP2C1 ATP2C2	4.26e-03	17	108	2	PF00689
Domain	Importin-beta_N	TNPO2 IPO9	4.26e-03	17	108	2	IPR001494
Domain	Cation_ATPase_N	ATP2C1 ATP2C2	4.77e-03	18	108	2	PF00690
Domain	Cation_ATPase_N	ATP2C1 ATP2C2	4.77e-03	18	108	2	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP2C1 ATP2C2	5.31e-03	19	108	2	IPR004014
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-25 ERVK-24	1.68e-09	94	123	8	21542922
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-10 ERVK-25 ERVK-24	4.21e-09	18	123	5	18664271
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-21 ERVK-9 ERVK-8 ERVK-19	7.21e-08	12	123	4	14557543
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-7 ERVK-10 ERVK-24	1.72e-07	4	123	3	10469592
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-7 ERVK-21 ERVK-19	4.29e-07	5	123	3	12629516
Pubmed	Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease.	NAT1 NAT2 INSR	4.29e-07	5	123	3	33296651
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RGPD4 CADM3 FMR1 MINK1 CNTNAP1 DGKG PRPF38B ERBIN MICU3 ATP2C1 PEBP1 RAB3GAP2 RGPD3 UBR3 ALDH1B1 CAP1 VCPIP1	5.80e-07	1139	123	17	36417873
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RAPGEF3 RGPD3	2.39e-06	8	123	3	21670213
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DENND4A TTC28 ERBIN NHS ROBO1 TNS3 VCPIP1	1.01e-05	209	123	7	36779422
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 CNTNAP1 RGPD3	1.20e-05	13	123	3	31427429
Pubmed	Differential gene expression in migrating cortical interneurons during mouse forebrain development.	CHL1 DGKG PTPRT	1.20e-05	13	123	3	20151419
Pubmed	Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China?	NAT1 NAT2	1.24e-05	2	123	2	15770721
Pubmed	Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.	NAT1 NAT2	1.24e-05	2	123	2	19549810
Pubmed	Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases.	NAT1 NAT2	1.24e-05	2	123	2	17656365
Pubmed	N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.	NAT1 NAT2	1.24e-05	2	123	2	12135032
Pubmed	Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.	NAT1 NAT2	1.24e-05	2	123	2	28888949
Pubmed	Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.	NAT1 NAT2	1.24e-05	2	123	2	17522066
Pubmed	Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2.	NAT1 NAT2	1.24e-05	2	123	2	1559981
Pubmed	Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.	NAT1 NAT2	1.24e-05	2	123	2	29214875
Pubmed	Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells.	ATP2C1 ATP2C2	1.24e-05	2	123	2	28618103
Pubmed	N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.	NAT1 NAT2	1.24e-05	2	123	2	26409796
Pubmed	Effects of microRNA-217 on proliferation, apoptosis, and autophagy of hepatocytes in rat models of CCL4-induced liver injury by targeting NAT2.	NAT1 NAT2	1.24e-05	2	123	2	30417525
Pubmed	Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.	NAT1 NAT2	1.24e-05	2	123	2	11266080
Pubmed	N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.	NAT1 NAT2	1.24e-05	2	123	2	19379125
Pubmed	Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice.	NAT1 NAT2	1.24e-05	2	123	2	29237750
Pubmed	Genetic regulation of aromatic amine N-acetylation in inbred mice.	NAT1 NAT2	1.24e-05	2	123	2	6976963
Pubmed	Update on consensus arylamine N-acetyltransferase gene nomenclature.	NAT1 NAT2	1.24e-05	2	123	2	10862519
Pubmed	Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter.	NAT1 NAT2	1.24e-05	2	123	2	22644701
Pubmed	Molecular genetic basis of rapid and slow acetylation in mice.	NAT1 NAT2	1.24e-05	2	123	2	1875909
Pubmed	NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant.	NAT1 NAT2	1.24e-05	2	123	2	15142281
Pubmed	5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion.	NAT1 NAT2	1.24e-05	2	123	2	24205029
Pubmed	Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.	NAT1 NAT2	1.24e-05	2	123	2	17961509
Pubmed	Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.	NAT1 NAT2	1.24e-05	2	123	2	18199719
Pubmed	Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.	NAT1 NAT2	1.24e-05	2	123	2	12037388
Pubmed	N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.	NAT1 NAT2	1.24e-05	2	123	2	19898993
Pubmed	Effects of genetic polymorphisms of N-Acetyltransferase on trichloroethylene-induced hypersensitivity dermatitis among exposed workers.	NAT1 NAT2	1.24e-05	2	123	2	19834256
Pubmed	Carcinogen metabolism, cigarette smoking, and breast cancer risk: a Bayes model averaging approach.	NAT1 NAT2	1.24e-05	2	123	2	21080951
Pubmed	Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk.	NAT1 NAT2	1.24e-05	2	123	2	14564055
Pubmed	Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.	NAT1 NAT2	1.24e-05	2	123	2	18006927
Pubmed	Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene.	NAT1 NAT2	1.24e-05	2	123	2	25798622
Pubmed	RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.	NAT1 NAT2	1.24e-05	2	123	2	21347396
Pubmed	Nat1 promotes translation of specific proteins that induce differentiation of mouse embryonic stem cells.	NAT1 NAT2	1.24e-05	2	123	2	28003464
Pubmed	Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.	NAT1 NAT2	1.24e-05	2	123	2	11751443
Pubmed	Arylamine N-acetyltransferase 2 expression in the developing heart.	NAT1 NAT2	1.24e-05	2	123	2	15872051
Pubmed	N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.	NAT1 NAT2	1.24e-05	2	123	2	25689677
Pubmed	Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.	NAT1 NAT2	1.24e-05	2	123	2	12355549
Pubmed	An N-ethyl-N-nitrosourea-induced mutation in N-acetyltransferase 1 in mice.	NAT1 NAT2	1.24e-05	2	123	2	18373979
Pubmed	Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.	NAT1 NAT2	1.24e-05	2	123	2	17537267
Pubmed	Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.	NAT1 NAT2	1.24e-05	2	123	2	23160945
Pubmed	Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts.	NAT1 NAT2	1.24e-05	2	123	2	15853926
Pubmed	In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria.	NAT1 NAT2	1.24e-05	2	123	2	12054539
Pubmed	Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.	NAT1 NAT2	1.24e-05	2	123	2	15717312
Pubmed	Dissection of the functional differences between human secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and 2 isoenzymes by steady-state and transient kinetic analyses.	ATP2C1 ATP2C2	1.24e-05	2	123	2	16332677
Pubmed	Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases.	NAT1 NAT2	1.24e-05	2	123	2	1676262
Pubmed	Arylamine N-acetyltransferases: a structural perspective.	NAT1 NAT2	1.24e-05	2	123	2	23517104
Pubmed	No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer.	NAT1 NAT2	1.24e-05	2	123	2	12692115
Pubmed	Chromosomal localization of human genes for arylamine N-acetyltransferase.	NAT1 NAT2	1.24e-05	2	123	2	8110178
Pubmed	Major effects on teratogen-induced facial clefting in mice determined by a single genetic region.	NAT1 NAT2	1.24e-05	2	123	2	2227380
Pubmed	Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention.	NAT1 NAT2	1.24e-05	2	123	2	12088198
Pubmed	Developmental expression of N-acetyltransferases in C57BI/6 mice.	NAT1 NAT2	1.24e-05	2	123	2	9929513
Pubmed	Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.	NAT1 NAT2	1.24e-05	2	123	2	16098511
Pubmed	Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.	NAT1 NAT2	1.24e-05	2	123	2	9070359
Pubmed	Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.	NAT1 NAT2	1.24e-05	2	123	2	23168701
Pubmed	Association of NAT1 and NAT2 genes with nonsyndromic cleft lip and palate.	NAT1 NAT2	1.24e-05	2	123	2	23660777
Pubmed	Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism.	NAT1 NAT2	1.24e-05	2	123	2	20026257
Pubmed	N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus.	NAT1 NAT2	1.24e-05	2	123	2	14705222
Pubmed	[The biological role of prokaryotic and eukaryotic N-acetyltransferase].	NAT1 NAT2	1.24e-05	2	123	2	23420430
Pubmed	A readout of metabolic efficiency in arylamine N-acetyltransferase-deficient mice reveals minor energy metabolism changes.	NAT1 NAT2	1.24e-05	2	123	2	30883722
Pubmed	Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.	NAT1 NAT2	1.24e-05	2	123	2	12682333
Pubmed	Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms.	NAT1 NAT2	1.24e-05	2	123	2	15127906
Pubmed	Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.	NAT1 NAT2	1.24e-05	2	123	2	17675654
Pubmed	Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.	NAT1 NAT2	1.24e-05	2	123	2	25413361
Pubmed	Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.	NAT1 NAT2	1.24e-05	2	123	2	16847422
Pubmed	Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1.	NAT1 NAT2	1.24e-05	2	123	2	10640510
Pubmed	Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.	NAT1 NAT2	1.24e-05	2	123	2	20570911
Pubmed	Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.	NAT1 NAT2	1.24e-05	2	123	2	19663877
Pubmed	Nomenclature for N-acetyltransferases.	NAT1 NAT2	1.24e-05	2	123	2	7773298
Pubmed	NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.	NAT1 NAT2	1.24e-05	2	123	2	25886288
Pubmed	Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk.	NAT1 NAT2	1.24e-05	2	123	2	11034589
Pubmed	Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.	NAT1 NAT2	1.24e-05	2	123	2	16981843
Pubmed	Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.	NAT1 NAT2	1.24e-05	2	123	2	12815173
Pubmed	Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice.	NAT1 NAT2	1.24e-05	2	123	2	12142728
Pubmed	Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.	NAT1 NAT2	1.24e-05	2	123	2	22193722
Pubmed	Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.	NAT1 NAT2	1.24e-05	2	123	2	18372103
Pubmed	Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study.	NAT1 NAT2	1.24e-05	2	123	2	18022202
Pubmed	Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.	NAT1 NAT2	1.24e-05	2	123	2	11431340
Pubmed	Functional expression of human arylamine N-acetyltransferase NAT110 and NAT111 alleles: a mini review.	NAT1 NAT2	1.24e-05	2	123	2	30222709
Pubmed	Arylamine N-acetyl transferase in mice.	NAT1 NAT2	1.24e-05	2	123	2	1397516
Pubmed	Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene.	NAT1 NAT2	1.24e-05	2	123	2	12815365
Pubmed	NAT2 variation and idiopathic talipes equinovarus (clubfoot).	NAT1 NAT2	1.24e-05	2	123	2	17726690
Pubmed	Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.	NAT1 NAT2	1.24e-05	2	123	2	15784508
Pubmed	Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.	NAT1 NAT2	1.24e-05	2	123	2	11060463
Pubmed	Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver.	NAT1 NAT2	1.24e-05	2	123	2	1968463
Pubmed	Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2.	NAT1 NAT2	1.24e-05	2	123	2	16507510
Pubmed	Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.	NAT1 NAT2	1.24e-05	2	123	2	19809881
Pubmed	Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.	NAT1 NAT2	1.24e-05	2	123	2	17403913
Pubmed	Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts.	NAT1 NAT2	1.24e-05	2	123	2	18161794
Pubmed	Meat consumption, N-acetyl transferase 1 and 2 polymorphism and risk of breast cancer in Danish postmenopausal women.	NAT1 NAT2	1.24e-05	2	123	2	18090909
Pubmed	Acute murine colitis reduces colonic 5-aminosalicylic acid metabolism by regulation of N-acetyltransferase-2.	NAT1 NAT2	1.24e-05	2	123	2	24742986
Pubmed	The effects of genetic variation in N-acetyltransferases on 4-aminobiphenyl genotoxicity in mouse liver.	NAT1 NAT2	1.24e-05	2	123	2	12902152
Cytoband	8p22	NAT1 NAT2 MICU3	1.68e-04	40	122	3	8p22
Cytoband	Ensembl 112 genes in cytogenetic band chr16q23	CPHXL2 PKD1L2 CPHXL OSGIN1	2.70e-04	116	122	4	chr16q23
Cytoband	Ensembl 112 genes in cytogenetic band chr8p22	NAT1 NAT2 MICU3	2.73e-04	47	122	3	chr8p22
GeneFamily	Arylamine N-acetyltransferases	NAT1 NAT2	4.42e-05	3	70	2	1133
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	GAK TNS3	4.08e-04	8	70	2	837
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT3 INSR LTK	4.96e-04	40	70	3	321
GeneFamily	ATPases Ca2+ transporting	ATP2C1 ATP2C2	5.23e-04	9	70	2	1209
GeneFamily	Integrator complex	INTS1 INTS14	1.50e-03	15	70	2	1366
GeneFamily	Dyneins, axonemal	DNAH1 DNAH17	1.94e-03	17	70	2	536
GeneFamily	Armadillo repeat containing\|Importins	TNPO2 IPO9	2.17e-03	18	70	2	596
GeneFamily	Fibronectin type III domain containing	CHL1 INSR PTPRT ROBO1	3.44e-03	160	70	4	555
GeneFamily	Immunoglobulin like domain containing	CHL1 CADM3 FLT3 PTPRT	6.67e-03	193	70	4	594
GeneFamily	Actins\|Deafness associated genes	OTOA TMC1 MYO3A	9.60e-03	113	70	3	1152
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD4 TTC28 RGPD3	1.01e-02	115	70	3	769
Coexpression	GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	TTC28 INSR NEU3 ANGPTL1 DMXL1 PARP6 MICU3 CHST15	1.01e-06	175	114	8	M2940
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 MYO1D PTPRT LPIN1 DYNC2LI1 DNAH17 TNS3	3.97e-07	177	115	7	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 POT1 GPR37L1 SLITRK6 TEDC1	5.34e-07	185	115	7	ca69499ba8c39b7ed6717d05685d6f70066a77bd
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 MYT1 GPR37L1 DGKG PTPRT ATP2C2 PDZD2	8.72e-07	199	115	7	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 MYT1 GPR37L1 DGKG PTPRT ATP2C2 PDZD2	8.72e-07	199	115	7	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 MYT1 GPR37L1 DGKG PTPRT ATP2C2 PDZD2	8.72e-07	199	115	7	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 MYT1 RAPGEF3 PEBP1 DHCR24 DNAH17	6.09e-06	174	115	6	46bd0ef7d0541386de7a901d85d53d0176dc92bf
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACOT6 RAPGEF3 ALDH1B1 EPHX3 DNMT3B TEDC1	6.50e-06	176	115	6	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT3 POT1 NEU3 DYSF WDFY4 ROBO1	6.72e-06	177	115	6	345cebc19f93970a9a46be139208b300081f5493
ToppCell	droplet-Limb_Muscle-nan-24m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MINK1 GPR37L1 BTBD16 DNAH17 DNMT3B	6.94e-06	178	115	6	f2002a5c4758d0af6c1880ca12f0af0d5e8888e4
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 NHS SLITRK6	7.88e-06	182	115	6	812ff2a50a510b18d865e89465dba1754a08ef61
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 GAS2L3 BTBD16 ATP2C2 TNS3 PDZD2	7.88e-06	182	115	6	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA MGAM PKD1L2 DNAH1 HMCN1 ROBO1	8.38e-06	184	115	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 FMO3 MKRN2OS GPR37L1 LTK SLITRK6	8.38e-06	184	115	6	6388c47b7f1d8203e3069eba0e74107256dcae51
ToppCell	CV-Healthy-7\|CV / Virus stimulation, Condition and Cluster	HAUS7 SLC26A2 POT1 ZNF829 DYNC2LI1 DHCR24	8.38e-06	184	115	6	0e5cc77aaa73ceb791f8be7456177577fd2e5586
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA MGAM PKD1L2 DNAH1 HMCN1 ROBO1	8.38e-06	184	115	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA MGAM PKD1L2 DNAH1 HMCN1 ROBO1	8.38e-06	184	115	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Heart-4Chambers-18m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 FMO3 MKRN2OS GPR37L1 LTK SLITRK6	8.38e-06	184	115	6	d83ae1dc64aa1b27d3b524c137567418cc0ff8c6
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 DHCR24 SLITRK6	8.92e-06	186	115	6	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	droplet-Marrow-nan-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSUN2 C1GALT1C1 PEBP1 ASS1 ALDH1B1 CLUH	9.48e-06	188	115	6	9fc3f17045606f1fe29d296326da9482db58433b
ToppCell	droplet-Marrow-nan-18m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSUN2 C1GALT1C1 PEBP1 ASS1 ALDH1B1 CLUH	9.48e-06	188	115	6	1ff13434dfe60c8184d5f33041e325eca41392bc
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 ACOT6 SLITRK6	9.48e-06	188	115	6	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 CADM3 MYT1 GPR37L1 DGKG PDZD2	1.01e-05	190	115	6	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 NSUN2 ERBIN TMEM65 ROBO1 CAP1	1.07e-05	192	115	6	ec1fd2fb6e71f87189d66261909a84e2be63cacb
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 SLC26A2 PRPF38B DHCR24 ASS1 SLITRK6	1.31e-05	199	115	6	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 MYT1 GPR37L1 DGKG DHCR24 PDZD2	1.35e-05	200	115	6	ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAS2L3 PTPRT ASS1 NHS SLITRK6	3.50e-05	143	115	5	24fd24846fbef049af669a57d42fcc18928d2b27
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3\|TCGA-Skin / Sample_Type by Project: Shred V9	TTC28 DMXL1 HMCN1 RAPGEF3 DNMT3B	5.81e-05	159	115	5	fb222c42f66901852b01cec073ec0732245ee973
ToppCell	PND03-Immune-Immune_Myeloid-DC-cDC1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT3 C17orf99 NAGA WDFY4 TEDC1	6.16e-05	161	115	5	0e2b54a63781397f6b99eb0e201fbb820cbd7cc6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMC1 PTPRT ASS1 PDZD2 TDRD12	7.33e-05	167	115	5	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CHL1 CADM3 GAS2L3 GPR37L1 SLITRK6	8.42e-05	172	115	5	8d6a2a0d5f63b09a5a304a77e600a647f87e9de4
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEU3 C2orf81 LPIN1 DUS2 ALG5	8.65e-05	173	115	5	62abaaaf48cabd1423f17fb27c33b75ea88867f4
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEU3 C2orf81 LPIN1 DUS2 ALG5	8.65e-05	173	115	5	09cd878c33534bd476d6a4880f5582076189da8c
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF3 ALDH1B1 EPHX3 DNMT3B TEDC1	8.65e-05	173	115	5	5d7c53c6d1cdd385e44b79b82faec901747d1736
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACOT6 RAPGEF3 ALDH1B1 EPHX3 TEDC1	8.89e-05	174	115	5	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	TMC1 GAS2L3 IPO9 ROBO1 TNS3	8.89e-05	174	115	5	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF3 ALDH1B1 EPHX3 DNMT3B TEDC1	8.89e-05	174	115	5	9eab43885496b8586f8ec5b4bcb1fd5b209218e5
ToppCell	COVID-19-kidney-REN+Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DGKG REN RAPGEF3 NHS ROBO1	8.89e-05	174	115	5	8393f0b43c767839c1630bcb952d62b42efc788d
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CHL1 GAS2L3 GPR37L1 NHS VCPIP1	9.38e-05	176	115	5	792f414f5092aba14260b8e16378e793a822498e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM TMC1 PEBP1 ASS1 PDZD2	1.02e-04	179	115	5	78fae47ec9bff4e0159a86a281e831d7f8ee925a
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GAS2L3 GPR37L1 INTS14 SLITRK6	1.04e-04	180	115	5	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GAS2L3 GPR37L1 INTS14 SLITRK6	1.04e-04	180	115	5	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GAS2L3 GPR37L1 INTS14 SLITRK6	1.04e-04	180	115	5	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 CADM3 GPR37L1 HMCN1 SLITRK6	1.07e-04	181	115	5	a436e7e4c36403257ea90160a58ca0d6d7c0cdfc
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A TNPO2 C17orf99 CDAN1 TEDC1	1.07e-04	181	115	5	e2d03115a87f45a7ddd3ade6b9ac3843639bd41a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 GAS2L3 ATP2C2 TNS3 PDZD2	1.07e-04	181	115	5	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A TNPO2 C17orf99 CDAN1 TEDC1	1.07e-04	181	115	5	d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GPR37L1 C2orf81 SLITRK6	1.10e-04	182	115	5	6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMO3 MYT1 GPR37L1 TNS3 PDZD2	1.10e-04	182	115	5	a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMO3 MYT1 GPR37L1 TNS3 PDZD2	1.10e-04	182	115	5	831b5ce46b41efe01c4db6016c2f43148611373d
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 SLITRK6	1.13e-04	183	115	5	876b4f128c2168fdae7488201ff44f19c06c8415
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 SLITRK6	1.13e-04	183	115	5	b190b650e61b1b20baf5e42d04acac82d3fd1400
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 MYT1 RAPGEF3 DHCR24 DNAH17	1.13e-04	183	115	5	83592c332b1e82673f993d37c7f480befdc3dcda
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 LPIN1 DYNC2LI1 DNAH17 TNS3	1.13e-04	183	115	5	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 SLITRK6	1.13e-04	183	115	5	8330c39184ce076e1f95fd3725b68af551d89db0
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMO3 MYT1 GPR37L1 DGKG TNS3	1.19e-04	185	115	5	2e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMO3 MYT1 GPR37L1 DGKG TNS3	1.19e-04	185	115	5	7aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCell	CV-Healthy-7\|Healthy / Virus stimulation, Condition and Cluster	HAUS7 SLC26A2 POT1 ZNF829 DYNC2LI1	1.19e-04	185	115	5	1979d189c204f4c2893e3170a514ee7d5523406c
ToppCell	10x5'-Liver-Myeloid_Dendritic-DC1\|Liver / Manually curated celltypes from each tissue	FLT3 NAGA C2orf81 WDFY4 ROBO1	1.22e-04	186	115	5	e823529ffd06352c6bdec102f221fdf27f7c7369
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 DENND4A NHS TNS3 PDZD2	1.22e-04	186	115	5	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GPR37L1 PTPRT BTBD16 SLITRK6	1.25e-04	187	115	5	16e55d802fc4e71878305e61ad03806aabd59537
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHL1 GAS2L3 GPR37L1 C2orf81 SLITRK6	1.25e-04	187	115	5	6f7f293c9cf35261e0e3614e46ec1fb00a701b63
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMO3 MYT1 GPR37L1 TNS3 PDZD2	1.25e-04	187	115	5	daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 DENND4A NHS TNS3 PDZD2	1.25e-04	187	115	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMO3 MYT1 GPR37L1 TNS3 PDZD2	1.25e-04	187	115	5	5b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 SLC26A2 INSR ATP2C2 ASS1	1.28e-04	188	115	5	5901b276f2379abf486b8285957277e95f08464e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 MYO1D PTPRT DYNC2LI1 TNS3	1.28e-04	188	115	5	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	droplet-Marrow-BM-1m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSUN2 ASS1 ALDH1B1 CLUH DNMT3B	1.31e-04	189	115	5	b81540e097e95158851e07bfd78640ed6e64c2cf
ToppCell	droplet-Heart-HEART-1m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 SLITRK6	1.31e-04	189	115	5	a618a1ddf5097a010c6c2c7341f3a0bd46a29c02
ToppCell	droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSUN2 ASS1 ALDH1B1 CLUH DNMT3B	1.31e-04	189	115	5	0fda1a3f1e87fadf5309c8267beaa4501983b1dd
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CADM3 GAS2L3 GPR37L1 SLITRK6	1.31e-04	189	115	5	4e61f9cd1c06bddb47ebf98affc0f97770e26e8c
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO1D FASTKD1 ZNF829 LPIN1 CHST15	1.34e-04	190	115	5	da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO1D FASTKD1 ZNF829 LPIN1 CHST15	1.34e-04	190	115	5	42312f7d79fe889397d32910b625793e2535cc26
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GAS2L3 GPR37L1 BTBD16 SLITRK6	1.34e-04	190	115	5	ff3dec5b45c6ea9b5319fb51a0198c6773b7be26
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO1D FASTKD1 ZNF829 LPIN1 CHST15	1.34e-04	190	115	5	682418a7a2096743112eae3790d40e7e600612c0
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 GAS2L3 GPR37L1 BTBD16 SLITRK6	1.34e-04	190	115	5	4971857eac9af17d66d673ed2ab7072639f60a10
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FMO3 MYO1D HMCN1 ROBO1 TNS3	1.41e-04	192	115	5	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FMO3 MYO1D HMCN1 ROBO1 TNS3	1.44e-04	193	115	5	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	XRN2 TTC28 RPS6KA3 ERBIN ROBO1	1.44e-04	193	115	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 SLC26A2 INSR ATP2C2 ASS1	1.55e-04	196	115	5	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	FLT3 DYSF ERBIN DHCR24 CAP1	1.55e-04	196	115	5	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 MYT1 GPR37L1 DGKG PDZD2	1.55e-04	196	115	5	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 MYT1 GPR37L1 DGKG PDZD2	1.55e-04	196	115	5	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	MGAM FLT3 MYO9B DYSF CHST15	1.59e-04	197	115	5	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT3 AKNA ZNF831 WDFY4 CHST15	1.59e-04	197	115	5	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 DENND4A INSR CHST15 RAB3GAP2	1.63e-04	198	115	5	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 DENND4A INSR CHST15 RAB3GAP2	1.63e-04	198	115	5	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 DENND4A INSR CHST15 RAB3GAP2	1.63e-04	198	115	5	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	proximal-Epithelial-Differentiating_Basal-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHL1 ATP2C2 ASS1 SLITRK6 EPHX3	1.67e-04	199	115	5	c607346f60e5997e757e5a31cab412ab3734377b
ToppCell	Caecum-(5)_Dendritic_cell-(51)_cDC1\|Caecum / shred on region, Cell_type, and subtype	FLT3 NAGA DYSF C2orf81 WDFY4	1.67e-04	199	115	5	2b97fda45241b2ce7be904cf081cabcf3eb5ba1d
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 SLC26A2 DHCR24 ASS1 SLITRK6	1.67e-04	199	115	5	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	proximal-3-Epithelial-Differentiating_Basal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHL1 ATP2C2 ASS1 SLITRK6 EPHX3	1.67e-04	199	115	5	12e07084fc2d5d4c418df564ccc0e132b056e549
ToppCell	proximal-Epithelial-Differentiating_Basal\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHL1 ATP2C2 ASS1 SLITRK6 EPHX3	1.67e-04	199	115	5	96a89a2578fad9a99c52d2cf9e26e06516a96568
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 SLC26A2 DHCR24 ASS1 SLITRK6	1.67e-04	199	115	5	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Caecum-Dendritic_cell-cDC1\|Caecum / Region, Cell class and subclass	FLT3 NAGA DYSF C2orf81 WDFY4	1.67e-04	199	115	5	9ab38a0060a883de6fe3da8cdac42e124d7981d9
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	CHL1 DENND4A GPR37L1 PTPRT PDZD2	1.71e-04	200	115	5	a6500d0d2e8bcac92381ab771dbdee66b0e1d48e
ToppCell	Sepsis-Bac-SEP-Myeloid-cDC1\|Bac-SEP / Disease, condition lineage and cell class	FLT3 GAS2L3 C2orf81 WDFY4 ROBO1	1.71e-04	200	115	5	cd381644fd8b8674a017d267bfbb00f2668294ae
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DGKG ANGPTL1 PARP6 MICU3 ATL2	1.71e-04	200	115	5	a372ef3f9e6ff6e3c3376d6e10182977c5067788
Drug	AC1L1IZE	MGAM INSR NAGA DNAH1 ATP2C1 DNAH17 ATP2C2	4.39e-06	131	114	7	CID000004799
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; HL60; HG-U133A	DENND4A GAK POT1 IMPACT DMXL1 DUS2 ATP2C1 ALDH1B1	6.85e-06	197	114	8	2003_DN
Drug	Narea	MGAM SLC26A2 NEU3	1.96e-05	11	114	3	CID000016556
Drug	2,5-dimethylquinone	MGAM ATP2C1 ATP2C2	1.96e-05	11	114	3	CID000008718
Drug	4-iodoaniline	NAT1 NAT2	2.49e-05	2	114	2	ctd:C013067
Drug	N-hydroxy-2-aminofluorene	NAT1 NAT2	2.49e-05	2	114	2	ctd:C001368
Drug	4-bromoaniline	NAT1 NAT2	2.49e-05	2	114	2	ctd:C023621
Drug	bromoacetanilide	NAT1 NAT2	2.49e-05	2	114	2	ctd:C056005
Drug	2-(bromoacetylamino)fluorene	NAT1 NAT2	2.49e-05	2	114	2	ctd:C075748
Drug	AC1LCT6N	NAT1 NAT2 MGAM	2.60e-05	12	114	3	CID000606283
Drug	mag-fura-2	MGAM ATP2C1 RAPGEF3 ATP2C2	3.47e-05	37	114	4	CID000123839
Drug	aspartimide	NAT1 NAT2 INSR	4.27e-05	14	114	3	CID000188987
Drug	3,2'-dimethyl-4-aminobiphenyl	NAT1 NAT2 DYSF	5.32e-05	15	114	3	CID000025948
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A	USP34 MINK1 HMG20A IPO9 DYNC2LI1 ALDH1B1 SMAD5	6.35e-05	198	114	7	5885_DN
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	USP34 DENND4A NAGA DUS2 DYNC2LI1 TBCE VCPIP1	6.76e-05	200	114	7	5831_DN
Drug	N-hydroxy-4-acetylaminobiphenyl	NAT1 NAT2	7.43e-05	3	114	2	ctd:C001365
Drug	3,5-dimethylaniline	NAT1 NAT2	7.43e-05	3	114	2	CID000007949
Drug	Aminosalicylic Acid	NAT1 NAT2	7.43e-05	3	114	2	ctd:D010131
Drug	I 324	NAT1 NAT2	7.43e-05	3	114	2	CID000031230
Drug	Hair Dyes	NAT1 NAT2	7.43e-05	3	114	2	ctd:D006202
Drug	Glu-asp-gly	NAT1 NAT2	7.43e-05	3	114	2	CID000194641
Drug	3-ethylaniline	NAT1 NAT2	7.43e-05	3	114	2	CID000011475
Drug	AC1L88YH	MGAM ATP2C1 ATP2C2	7.90e-05	17	114	3	CID000374551
Disease	occupational dermatitis (is_implicated_in)	NAT1 NAT2	1.40e-05	2	111	2	DOID:4404 (is_implicated_in)
Disease	hearing impairment	OTOA TMC1 RPS6KA3 MYO3A FOXI1	3.54e-05	98	111	5	C1384666
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	OTOA TMC1 MYO3A FOXI1	4.14e-05	51	111	4	cv:CN043650
Disease	cytotoxicity measurement, response to clozapine	MYT1 HMCN1 CHST15	1.76e-04	29	111	3	EFO_0006952, GO_0097338
Disease	Nonsyndromic genetic hearing loss	OTOA TMC1 MYO3A FOXI1	1.98e-04	76	111	4	cv:C5680182
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2C1 ATP2C2	2.08e-04	6	111	2	DOID:0050429 (implicated_via_orthology)
Disease	allergic contact dermatitis (is_implicated_in)	NAT1 NAT2	2.08e-04	6	111	2	DOID:3042 (is_implicated_in)
Disease	Joubert syndrome (implicated_via_orthology)	INPP5E TOGARAM1	2.91e-04	7	111	2	DOID:0050777 (implicated_via_orthology)
Disease	Craniofacial Abnormalities	FMR1 SLC26A2 TBCE FOXI1 DNMT3B	3.16e-04	156	111	5	C0376634
Disease	Industrial Dermatosis	NAT1 NAT2	3.87e-04	8	111	2	C0086457
Disease	Dermatitis, Occupational	NAT1 NAT2	3.87e-04	8	111	2	C0028796
Disease	5-acetylamino-6-formylamino-3-methyluracil measurement	NAT1 NAT2	4.96e-04	9	111	2	EFO_0800950
Disease	renal cell carcinoma	POT1 INSR PDZD2	5.34e-04	42	111	3	EFO_0000681
Disease	Facies	FMR1 TBCE	6.19e-04	10	111	2	C0282631
Disease	Joubert syndrome (is_implicated_in)	INPP5E TOGARAM1	6.19e-04	10	111	2	DOID:0050777 (is_implicated_in)
Disease	alpha wave measurement, electroencephalogram measurement	DNAH1 TNS3	6.19e-04	10	111	2	EFO_0004357, EFO_0006870
Disease	Gastric Adenocarcinoma	RPS6KA3 MINK1 INSR	6.55e-04	45	111	3	C0278701
Disease	end stage renal disease (biomarker_via_orthology)	NAT1 NAT2 LPIN1	7.45e-04	47	111	3	DOID:783 (biomarker_via_orthology)
Disease	5-acetylamino-6-amino-3-methyluracil measurement	NAT1 NAT2	7.54e-04	11	111	2	EFO_0800951
Disease	Cognitive impairment	PTPRT DMXL1	7.54e-04	11	111	2	HP_0100543
Disease	N-acetylputrescine measurement	NAT1 NAT2	9.03e-04	12	111	2	EFO_0800127
Disease	prostate cancer (is_implicated_in)	NAT1 NAT2 FLT3 PEBP1	1.01e-03	117	111	4	DOID:10283 (is_implicated_in)
Disease	smoking status measurement, ulcerative colitis	WDFY4 PARP6	1.06e-03	13	111	2	EFO_0000729, EFO_0006527
Disease	PROSTATE CANCER, HEREDITARY, 1	TTC28 MYO9B DNMT3B	1.52e-03	60	111	3	C4722327
Disease	Chromosome Aberrations	NAT1 POT1	1.63e-03	16	111	2	C0008625
Disease	Autosome Abnormalities	NAT1 POT1	1.63e-03	16	111	2	C0004403
Disease	Prostate cancer, familial	TTC28 MYO9B DNMT3B	2.27e-03	69	111	3	C2931456
Disease	Hereditary hearing loss and deafness	OTOA TMC1 MYO3A FOXI1	2.29e-03	146	111	4	cv:C0236038
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAH17 SLITRK6	2.30e-03	19	111	2	DOID:10003 (implicated_via_orthology)
Disease	urate measurement, bone density	NAT1 TTC28 ERBIN HMG20A DNAH1 ASS1 ROBO1 PDZD2	2.39e-03	619	111	8	EFO_0003923, EFO_0004531
Disease	lung cancer (is_implicated_in)	NAT2 XRN2 POT1	2.77e-03	74	111	3	DOID:1324 (is_implicated_in)
Disease	Disproportionate short stature	SLC26A2 DHCR24 TBCE	3.10e-03	77	111	3	C0878659
Disease	Nonsyndromic Deafness	OTOA TMC1 MYO3A	3.57e-03	81	111	3	C3711374

Protein segments in the cluster

Peptide	Gene	Start	Entry
MWQPLELISGKDQPQ	NAT1	131	P18440
MWLSDNQSKPLIPLQ	ERBIN	396	Q96RT1
GDPNPWLQIDLMKKH	CNTNAP1	66	P78357
PGDSLEDQLKPMLEW	DNMT3B	321	Q9UBC3
EKWLEMNLVPLGGTQ	BTBD16	231	Q32M84
LEKGLNDLQPWPNQM	ALG5	176	Q9Y673
NFPLVMQGWKLAPAL	ALDH1B1	186	P30837
ESIQALGWVAMAPKP	CAP1	136	Q01518
QPMGLLWALEPEKAL	ACOT6	76	Q3I5F7
KPLDWLDPMPCFQNL	LINC02910	106	Q8N268
IKPENSNGPMQLWCE	ANGPTL1	296	O95841
LWEKEGSVPPLKMTQ	CADM3	266	Q8N126
LNIPEKCPEQGGMIW	C1GALT1C1	201	Q96EU7
RSVPGIPWLMNEQKL	CC2D2B	656	Q6DHV5
LLNMLPAMQKDDPTW	DMXL1	1586	Q9Y485
MLLSLWKEDFQGPVP	CDAN1	1116	Q8IWY9
AMQILWINIIMDGPP	ATP2C1	731	P98194
AMQILWINIIMDGPP	ATP2C2	761	O75185
IPVTPKNPWSMDENL	ASS1	171	P00966
LWDNMKLHQDPGQPL	DENND4A	1721	Q7Z401
ADVSNELPGLKWMPG	NSUN2	346	Q08J23
ELWALEPFPKMLGLL	OTOA	331	Q7RTW8
LPPTLCTWLKAMDPQ	RAB3GAP2	1331	Q9H2M9
NIPWLFLTDPKLAME	FMO3	446	P31513
QASQPKEMIIKWEPL	CHL1	721	O00533
KWEPLKSMEQNGPGL	CHL1	731	O00533
WNMQGQKELPPSLDE	INPP5E	306	Q9NRR6
LEMWLQNPKLTRPAQ	INTS1	371	Q8N201
MLGNEWSKLPPEEKQ	HMG20A	136	Q9NP66
MPLAQLADPWQKMAV	RPS6KA3	1	P51812
PQNPERSLKFDGMWI	MGAM	2301	O43451
NELLPWEPKLMKAFQ	KIAA2026	816	Q5HYC2
LEWLDMGSNKLEQLP	LRRC39	201	Q96DD0
DLSKPNDLWPTMENL	DYNC2LI1	116	Q8TCX1
QKKWQGLQEMRLPSP	LTK	451	P29376
SIIPQMLVNLWGPDK	OR2W1	76	Q9Y3N9
AWNIMKSVPEGPVQL	PDZD2	2816	O15018
MPVDLSKWSGPLSLQ	PEBP1	1	P30086
PWMNNIELVDLKPLP	FRYL	1311	O94915
QKNPEMLWLWGELPQ	LPIN1	266	Q14693
LNQMLAETPPVWKGS	MICU3	191	Q86XE3
VVHLMWQEPKEPNGL	INSR	866	P06213
DDPKWTLCLQVMLPN	IMPACT	46	Q9P2X3
KVPSPALGWDSVNLM	PKD1L2	1671	Q7Z442
TWMKDGRPLPQTDQV	HMCN1	3561	Q96RW7
QINTWEKPMLDQAVP	PTPRT	56	O14522
WPIGLKEPQIQMTVT	FANCD2OS	136	Q96PS1
PPRWAEDQNSLLKMI	RGPD3	801	A6NKT7
GNARLPVKWMAPESL	FLT3	846	P36888
NKLLPMQVDGEPWMQ	DGKG	741	P49619
PWENSSMRGLNPKIL	GAK	721	O14976
WINMGLEPGSLDRKP	DNAH1	261	Q9P2D7
LLKVPEPINLQWVMA	DNAH1	3996	Q9P2D7
ESQKPELKAWQGMVP	FMR1	386	Q06787
DQKMEDWQGPLESPI	C17orf99	216	Q6UX52
NMPPVAGQLKWSLEL	DNAH17	581	Q9UFH2
LWDTRNMKQPLADTP	DPH7	266	Q9BTV6
MELWRQLNQAGLVPP	ERICH4	1	A6NGS2
EQLPMDSGPWDLEKQ	CPHXL2	306	A0A1W2PPK0
MQPAIQVWFGEDLPL	GAS2L3	1	Q86XJ1
ELLLWQLAQEPAPTM	GPR37L1	266	O60883
GWMVPPKISLLKLTQ	DHCR24	356	Q15392
PWLGKMAQLGPISDA	INTS14	361	Q96SY0
LGQLPEMPWESNIEI	FASTKD1	751	Q53R41
LWEQVLKPLGDNLME	ATL2	541	Q8NHH9
LLQKGPAPAWLSMEM	C1orf112	821	Q9NSG2
MLLNPECDPWPLDMQ	HAUS7	176	Q99871
ECDPWPLDMQPLLNK	HAUS7	181	Q99871
PLDMQPLLNKQSDDW	HAUS7	186	Q99871
EPLAWLPQQGRQLDM	AKNA	106	Q7Z591
LPWLPEKLLSMSDFQ	EPHX3	226	Q9H6B9
MWQPLELISGKDQPQ	NAT2	131	P11245
PEAWPQLFNLLMEML	IPO9	141	Q96P70
SQVMWKPVLLPEALK	C2orf81	521	A6NN90
PEALKLAPGVSMWNR	C2orf81	531	A6NN90
DLGWLPIPSQEELMK	FOXI1	106	Q12951
MWNPSIFLKEGLRPL	DUS2	246	Q9NX74
WKMVPGINDSNILPL	C5orf34	436	Q96MH7
PQNSLPDIVIWMLQG	DYSF	786	O75923
QEQLPMDSGPWDLGK	CPHXL	331	A0A1W2PPM1
LSQGQWMGLPDLEVK	OSGIN1	141	Q9UJX0
QMDKLDPLAHPLLQW	PARP6	406	Q2NL67
KKSPPGNDDQLWLVM	MINK1	91	Q8N4C8
PPRWAEDQNSLLKMI	RGPD4	801	Q7Z3J3
EHCLLKEMQQWSIPP	TRNT1	371	Q96Q11
LLQLKTWLENMPPQS	SLITRK6	226	Q9H5Y7
MENANLPTKQEPSWI	NHS	901	Q6T4R5
KLNPALTLWPMFLQG	TDRD12	236	Q587J7
LGPEWSQPMKRLTLG	REN	56	P00797
PSWTLLKLCDVQPMQ	POT1	146	Q9NUX5
VMLLPVLGSFWNKDP	WFDC9	16	Q8NEX5
LTKLNPKIMDVGWPE	TNS3	61	Q68CZ2
WKVLPQGMLNSPTIC	ERVK-9	1081	P63128
WLDKVLTQMGSPLNP	SMAD5	446	Q99717
PSWMAKILRQLSNPG	TMC1	686	Q8TDI8
EDRNLGPMWPITQKI	CHST15	521	Q7LFX5
PLQCLKVLTMSGWNP	CLUH	211	O75153
QLVQWGPLKPLMEAT	NEU3	66	Q9UQ49
MKARNLPVWLPNQDE	RAPGEF3	531	O95398
LLQQWGAEITMPAPL	ERVK-9	96	P63127
LLQQWGAEITMPAPL	ERVK-24	96	P63129
GWEESISIPLLQPNM	MKRN2OS	106	H3BPM6
GAPEDWELKTQQPLM	TBCE	426	Q15813
KNMILGFLPVLQWLP	SLC26A2	86	P50443
LLQQWGVEITMPAPL	HERVK_113	96	P63121
VLPLWGNEKTMNLNP	PRPF38B	46	Q5VTL8
ASKGELQMWPELLPQ	TNPO2	116	O14787
WLLARGPVPEQMLAQ	TEDC1	116	Q86SX3
GAEPLLPWNRMLQTQ	XRN2	886	Q9H0D6
LLQQWGAEITMPAPL	ERVK-7	96	P63131
GPKDSLDAMLQWLLQ	WDFY4	1736	Q6ZS81
LLQQWGAEITMPAPL	ERVK-25	96	P63125
TPKVPKQGGMNWADL	ROBO1	1171	Q9Y6N7
LMSEEAKRGAPNPWL	STX8	111	Q9UNK0
MNLLPKAWGVPQDLI	VCPIP1	371	Q96JH7
LLQQWGAEITMPAPL	ERVK-10	96	P10265
PAVISLLEQGKEPWM	ZNF829	81	Q3KNS6
KMPDVELFVNLGDWP	POGLUT2	226	Q6UW63
LSIPDLTPKQVDMWQ	TMEM65	186	Q6PI78
IGNPKLPSAVMDRWL	TTC28	1486	Q96AY4
PWRKLTQLEEMNPQL	UBR3	1506	Q6ZT12
WKVLPQGMLNSPTIC	ERVK-19	161	Q9WJR5
FMDLWNLFQPKLSEP	USP34	2776	Q70CQ2
KNKLPWENEQPGIMG	TOGARAM1	656	Q9Y4F4
WGQDPPVQLRSQLML	nan	6	Q6ZVU0
MPQHQVSEPEWKKGL	ZNF831	1256	Q5JPB2
LLQQWGAEITMPAPL	ERVK-8	96	P63122
LLQQWGAEITMPTPL	ERVK-21	96	P63119
LLQQWGAEITMPAPL	HERV-K104	96	P63124
LLQQWGAEITMPAPL	ERVK-19	96	P63120
PVLKNMWPEGKLSIT	MYO1D	541	O94832
DNWPLLDMFLQKPMG	MYO3A	771	Q8NEV4
LMLDNGLLQTPPMGW	NAGA	16	P17050
MIKSIKGLPWQGEDP	MYO9B	746	Q13459
WEMPENLSTKPQDLP	MYT1	641	Q01538